Comparative study of two automated high-sensitivity C-reactive protein methods in a large population

Clinical Biochemistry

Volumn 38, Issue 1, 2005, Pages 31-35

  Lolekha, Porntip H ^a   Chittamma, Anchalee ^a   Roberts, William L ^b   Sritara, Piyamitr ^a   Cheepudomwit, Sayan ^a   Suriyawongpaisal, Paibul ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

C reactive protein; Coronary heart disease; CRP; High sensitivity CRP; hs CRP; InterASIA study; Large population; Ultrasensitive CRP

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; ASIAN; ATHEROSCLEROSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE; TURBIDIMETRY;

C-REACTIVE PROTEIN; CORONARY DISEASE; HUMANS; RISK FACTORS;

EID: 10644271903     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.09.001     Document Type: Article

References (34)

1. J. Whicher, L. Biasucci, and N. Rifai Inflammation, the acute phase response and atherosclerosis Clin. Chem. Lab. Med. 37 1999 495 503
2. M. Pepys C-reactive protein fifty years on Lancet I 1981 653 656
3. R.M.H. Rouman, P.A. van Meurs, H.H.C. Kuypers, W.A.G. Kraak, and R.W. Sauerwein Serum interleukin-6 and C-reactive protein responses in patients after laparoscopic or conventional cholecystectomy Eur. J. Surg. 158 1992 541 544
4. R.P. Tracy, L.H. Kuller, B.M. Psaty, M. Cuhman, E.N. Meilahn, and N. Smith C-reactive protein and incidence of cardiovascular disease in older women: the Rural Health Promotion Project and the Cardiovascular Health Study Circulation 93 1996 622 628
5. G. Liuzzo, L.M. Biasucci, and J.R. Gallimore The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina N. Engl. J. Med. 331 1994 417 424
6. L.H. Kuller for the MRFIT Research Group The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Intervention Trial Am. J. Epidemiol. 134 1991 266 277
7. F. Haverkate, S. Thompson, and F. Duckert Haemostasis factors in angina pectoris, relation to gender, age, and acute-phase reaction Thromb. Haemostasis 73 1995 61 67
8. A. Wasunna, A. Whitelaw, R. Gallimore, P.N. Hawkins, and M.B. Pepys C-reactive protein and bacterial infection in preterm infants Eur. J. Pediatr. 149 1990 424 427
9. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N. Engl. J. Med. 342 2000 836 843
10. P.M. Ridker, R.J. Glynn, and C.H. Hennekens C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction [see comments] Circulation 97 1998 2007 2011
11. T.A. Pearson, G.A. Mensah, and R.W. Alexander Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and prevention and the American Heart Association Circulation 107 2003 499 511
12. G.H. Clark, and C.G. Fraser Biological variation of acute phase proteins Ann. Clin. Biochem. 30 1993 373 376
13. E.M. Macy, T.E. Hayes, and R.P. Tracy Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications Clin. Chem. 43 1997 52 58
14. M.P.M. de Maat, A.C.W. de Bart, and B.C. Hennis Interindividual and intraindividual variability in plasma fibrinogen. TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris Arterioscler., Thromb., Vasc. Biol. 16 1996 1556 1562
15. W.L. Roberts, R. Sedrick, L. Moulton, A. Spencer, and N. Rifai Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications Clin. Chem. 46 2001 461 468
16. W.L. Roberts, L. Moulton, and T.C. Law Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2 Clin. Chem. 47 2001 418 425
17. N. Rifai, and P.M. Ridker High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease Clin. Chem. 47 2001 403 411
18. A. Hamwi, T. Vukovich, and O. Wagner Evaluation of turbidimetric high-sensitivity C-reactive protein assays for cardiovascular risk estimation Clin. Chem. 47 2001 2044 2046
19. K.S. Rothkrantz, M.P.J. Schmitz, O. Bekers, P.C.A.P. Menheere, and P.M. vanDieijen-Visser High-sensitivity C-reactive protein methods examined Clin. Chem. 48 2002 359 362
20. Kimberly MM, Barr JR, Vesper MW, Myers GL, Cooper GR. Standardization of hsCRP: report from the forum for manufacturers. AACC Lipoproteins and Vascular Diseases Division Newsletter 2001;15(2):5, 11-2.
21. M.M. Kimberly, M.W. Vesper, and S.P. Caudill Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials Clin. Chem. 49 2003 611 616
22. The interASIA Collaborative Group Cardiovascular risk factor levels in urban and rural Thailand-The International Collaborative Study of Cardiovascular Disease in Asia (InterASIA) Eur. J. Cardiovasc. Prev. Rehabil. 10 2003 249 257
23. T.B. Ledue, D.L. Weiner, J.D. Sipe, S.E. Poulin, M.F. Collins, and N. Rifai Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum Ann. Clin. Biochem. 35 1998 745 753
24. N. Rifai, R.P. Tracy, and P.M. Ridker Clinical efficacy of an automated high-sensitivity C-reactive protein assay Clin. Chem. 45 1999 2136 2141
25. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet i 1986 307 310
26. P. Armitage, and G. Berry Statistical methods in medical research Third ed. 1994 Blackwell Science Ltd Oxford 443 445
27. N. Devleeschouwer, J.C. Libeer, and J.P. Chapelle Factors influencing between-laboratory variability of C-reactive protein results as evidence by the Belgian External Quality Assessment (EQA) scheme Scand. J. Clin. Lab. Invest. 54 1994 435 4040
28. College of American Pathologists Cardiac Risk Participant Surveys Report 2002 College of American Pathologists Chicago
29. P. Tarkkinen, T. Palenius, and T. Lovgren Ultrarapid, ultrasensitive one-step kinetic immunoassay for C-reactive protein (CRP) in whole blood samples: measurement of a single sample dilution Clin. Chem. 48 2002 269 277
30. T.B. Ledue, and N. Rifai Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment Clin. Chem. 49 2003 1258 1271
31. S. Yamada, T. Gotoh, and Y. Nakashima Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese-population: Jichi Medical School Cohort Study Am. J. Epidemiol. 153 2001 1183 1190
32. N. Rifai, and P.M. Ridker Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation [Technical Brief] Clin. Chem. 49 2003 666 669
33. A. Imhof, M. Frohlich, and H. Loewel Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe [Technical Brief] Clin. Chem. 49 2003 669 672
34. E.S. Ford, W.H. Giles, G.L. Myers, and D.M. Mannino Population distribution of high-sensitivity C-reactive protein among US men: findings from National Health and Nutrition Examination Survey 1999-2000 Clin. Chem. 49 2003 686 690